Pfizer : PFE

All Pfizer Articles

1491 Articles

Douglas A. McIntyre | Jul 24, 2012 at 6:41 AM EDT

Media Digest (7/24/2012) Reuters, WSJ, NYT, FT, Bloomberg

Carlyle (NASDAQ: CG) may buy a unit of United Technologies (NYSE: UTX). (Reuters) More factories move to the United States…

Douglas A. McIntyre | Jul 20, 2012 at 6:29 AM EDT

Ten Ways You’ll Know The Recession Is Over

When Gallup asked people about the state of the economy this spring, as a recovery appeared to have taken hold,…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Douglas A. McIntyre | Jun 29, 2012 at 6:50 AM EDT

The Best-Selling Products of All Time

Some products sell well when first introduced. Many more fail miserably. Very few of them sell so well that they…

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

Douglas A. McIntyre | Jun 1, 2012 at 6:23 AM EDT

Media Digest (6/1/2012) Reuters, WSJ, NYT, FT, Bloomberg

China’s PMI indicates a considerable slowing of its economy. (Reuters) Senior EC and ECB officials warn that the eurozone is on…

Jon C. Ogg | May 31, 2012 at 11:13 AM EDT

Investors Flocking To Defensive Shares With High Dividends (PEP, KO, BUD, TAP, AWK, AEP, XLU, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

The 10-year Treasury hit yet another record low under 1.6% today and stocks are in the tank again due to…

Jon C. Ogg | May 14, 2012 at 1:14 PM EDT

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

A stock market that sells off eight of nine days is not a good market. Even the Facebook IPO is…

Paul Ausick | May 10, 2012 at 11:03 AM EDT

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, BPI)

The energy sector saw a lot of activity from short sellers in April, but other stocks saw some action as…

Trey Thoelcke | May 10, 2012 at 6:27 AM EDT

Media Digest (5/10/12) Reuters, WSJ, NYT, FT, Bloomberg

Sony (NYSE: SNE) says it will return to profit and will cut its TV unit losses in half. (Reuters) Cisco…

Jon C. Ogg | May 8, 2012 at 12:07 PM EDT

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Blame whatever you want. A weaker U.S. economy, a weakening and flailing Europe, a move to socialism in France and…

1 … 75 76 77 78 79 … 100

Pfizer : PFE

All Pfizer Articles

Media Digest (7/24/2012) Reuters, WSJ, NYT, FT, Bloomberg

Ten Ways You’ll Know The Recession Is Over

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

The Best-Selling Products of All Time

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Media Digest (6/1/2012) Reuters, WSJ, NYT, FT, Bloomberg

Investors Flocking To Defensive Shares With High Dividends (PEP, KO, BUD, TAP, AWK, AEP, XLU, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, BPI)

Media Digest (5/10/12) Reuters, WSJ, NYT, FT, Bloomberg

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Google, SpaceX, Microsoft, and Amazon Are About to Spend ‘Twice the Entire U.S. Defense Budget’ on AI

SECURE 2.0 Changes Force High Earners to Rethink 401(k) Strategy. Here's the Math.

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Pfizer : PFE

All Pfizer Articles

Media Digest (7/24/2012) Reuters, WSJ, NYT, FT, Bloomberg

Ten Ways You’ll Know The Recession Is Over

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

The Best-Selling Products of All Time

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Media Digest (6/1/2012) Reuters, WSJ, NYT, FT, Bloomberg

Investors Flocking To Defensive Shares With High Dividends (PEP, KO, BUD, TAP, AWK, AEP, XLU, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

Short Sellers Cast a Wide Net (ACI, XCO, SD, FST, XOM, DUK, AMD, SNY, PFE, NOK, BKS, SVU, PBI, DV, BPI)

Media Digest (5/10/12) Reuters, WSJ, NYT, FT, Bloomberg

The Market Where Defensive Shares Are Working Again (PEP, KO, BUD, TAP, AWK, MCD, KFT, CAG, CPB, HRL, MO, VGR, RAI, PG, KMB, CL, MRK, PFE, JNJ, T, VZ)

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

Jim Cramer: CoreWeave’s Backlog ‘May Be Much Greater’ Than Wall Street Thinks

Google, SpaceX, Microsoft, and Amazon Are About to Spend ‘Twice the Entire U.S. Defense Budget’ on AI

Featured Reads

SECURE 2.0 Changes Force High Earners to Rethink 401(k) Strategy. Here's the Math.

The RFK Jr. Medicare AI Program Already Denying Seniors Care in 6 States